WHO Prequalifies a 2nd generic DMPA product with Concept Foundation support

folder_openFamily Planning

Concept Foundation is happy to announce that Incepta Pharmaceuticals (Bangladesh) has been awarded WHO Prequalification of their intramuscular (IM) depot medroxyprogesterone acetate (DMPA) 150 mg/ml product. The Incepta product adds a second generic DMPA product to the WHO PQ list, alongside Mylan’s product, thereby increasing the volume of quality assured 3 monthly injectable contraception available worldwide

Read More